mirror of
https://github.com/qdrant/landing_page.git
synced 2026-09-29 16:08:32 +02:00
Update Blog “insight-generation-platform-for-lifescience-corporation-hooman-sedghamiz-vector-space-talks-014”
This commit is contained in:
+17
-13
@@ -3,10 +3,10 @@ draft: true
|
||||
title: Insight Generation Platform for LifeScience Corporation - Hooman
|
||||
Sedghamiz | Vector Space Talks
|
||||
slug: insight-generation-platform
|
||||
short_description: Hooman Sedghamiz explores the untapped potential of large
|
||||
language models in creating cutting-edge applications.
|
||||
description: Hooman Sedghamiz unfolds the potential of AI in life sciences, from
|
||||
custom knowledge applications to improving crop yield predictions, while
|
||||
short_description: Hooman Sedghamiz explores the potential of large language
|
||||
models in creating cutting-edge AI applications.
|
||||
description: Hooman Sedghamiz discloses the potential of AI in life sciences,
|
||||
from custom knowledge applications to improving crop yield predictions, while
|
||||
tearing apart the nuances of in-house AI deployment for multi-faceted
|
||||
enterprise efficiency.
|
||||
preview_image: /blog/from_cms/hooman-sedghamiz-bp-cropped.png
|
||||
@@ -22,7 +22,7 @@ tags:
|
||||
-- Hooman Sedghamiz
|
||||
>
|
||||
|
||||
Hooman Sedghamiz**,** Sr. Director AI/ML - Insights at Bayer AG is a distinguished figure in AI and ML in the life sciences field. With a wealth of experience, he has led teams and projects that have greatly advanced medical products, including implantable and wearable devices. Notably, he served as the Generative AI product owner and senior director at Bayer Pharmaceuticals, where he played a pivotal role in developing a GPT-based central platform for precision medicine.
|
||||
Hooman Sedghamiz**,** Sr. Director AI/ML - Insights at Bayer AG is a distinguished figure in AI and ML in the life sciences field. With years of experience, he has led teams and projects that have greatly advanced medical products, including implantable and wearable devices. Notably, he served as the Generative AI product owner and senior director at Bayer Pharmaceuticals, where he played a pivotal role in developing a GPT-based central platform for precision medicine.
|
||||
|
||||
In 2023, he assumed the role of Co-Chair for the EMNLP 2023 GEM industrial track, furthering his contributions to the field. Hooman has also been an AI/ML advisor and scientist at the University of California, San Diego, leveraging his expertise in deep learning to drive biomedical research and innovation. His strengths lie in guiding data science initiatives from inception to commercialization and bridging the gap between medical and healthcare applications through MLOps, LLMOps, and deep learning product management. Engaging with research institutions and collaborating closely with Dr. Nemati at Harvard University and UCSD, Hooman continues to be a dynamic and influential figure in the data science community.
|
||||
|
||||
@@ -36,7 +36,7 @@ In 2023, he assumed the role of Co-Chair for the EMNLP 2023 GEM industrial track
|
||||
|
||||
Why is real-time evaluation critical in maintaining the integrity of chatbot interactions and preventing issues like promoting competitors or making false promises? What strategies do developers employ to minimize cost while maximizing the effectiveness of model evaluations, specifically when dealing with LLMs? These might be just some of the many questions people in the industry are asking themselves. We aim to cover most of it in this talk.
|
||||
|
||||
Check out their conversation as they dive into the intricate world of AI chatbot evaluations. Discover the nuances of ensuring your chatbot's quality and continuous improvement across various metrics.
|
||||
Check out their conversation as they peek into world of AI chatbot evaluations. Discover the nuances of ensuring your chatbot's quality and continuous improvement across various metrics.
|
||||
|
||||
Here are the key topics of this episode:
|
||||
|
||||
@@ -46,6 +46,7 @@ Here are the key topics of this episode:
|
||||
4. **Cost-Effective Evaluation Models**: Discussion on employing smaller models for evaluation to reduce costs without compromising the depth of analysis, focusing on failure cases and root-cause assessments.
|
||||
5. **Tailored Evaluation Metrics**: Emphasis on the necessity of customizing evaluation criteria to suit specific use case requirements, including an exploration of the different metrics applicable to diverse scenarios.
|
||||
|
||||
>Fun Fact: Large language models like Mistral, Llama, and Nexus Raven have improved in their ability to perform function calling with low hallucination and high-quality output.
|
||||
|
||||
>
|
||||
|
||||
@@ -75,13 +76,16 @@ Here are the key topics of this episode:
|
||||
|
||||
## Transcript:
|
||||
Demetrios:
|
||||
We are here and I couldn't think of a better way to spend my Valentine's Day than with you Hooman this is absolutely incredible. I'm so excited for this talk that you're going to bring and I want to let everyone that is out there listening know what caliber of of speaker we have with us today because you have done a lot of stuff. Folks out there do not let this man's young look fool you. You look like you are not in your. When it comes to your bio, it looks like you should be in your very excited. You've got a lot of experience running data science projects, ML projects, LLM projects, all that fun stuff. You're working at Bayern Munich, sorry, not Bayern Munich, Bayer AG. And you're the senior director of AI and ML.
|
||||
We are here and I couldn't think of a better way to spend my Valentine's Day than with you Hooman this is absolutely incredible. I'm so excited for this talk that you're going to bring and I want to let everyone that is out there listening know what caliber of a speaker we have with us today because you have done a lot of stuff. Folks out there do not let this man's young look fool you. You look like you are not in your fifty's or sixty's. But when it comes to your bio, it looks like you should be in your seventy's. I am very excited. You've got a lot of experience running data science projects, ML projects, LLM projects, all that fun stuff. You're working at Bayern Munich, sorry, not Bayern Munich, Bayer AG. And you're the senior director of AI and ML.
|
||||
|
||||
|
||||
Demetrios:
|
||||
And I think that there is a ton of other stuff that you've done when it comes to machine learning, artificial intelligence. You've got both like the traditional ML background, I think, and then you've also got this new generative AI background and so you can leverage both. But you also think about things in data engineering way. You understand the whole lifecycle. And so today we get to talk all about some of this fun. I know you've got some slides prepared for us. I'll let you throw those on and I'll let anyone else in the chat. Feel free to ask questions while humin is going through the presentation and I'll jump in and stop them when needed.
|
||||
And I think that there is a ton of other stuff that you've done when it comes to machine learning, artificial intelligence. You've got both like the traditional ML background, I think, and then you've also got this new generative AI background and so you can leverage both. But you also think about things in data engineering way. You understand the whole lifecycle. And so today we get to talk all about some of this fun. I know you've got some slides prepared for us. I'll let you throw those on and I'll let anyone else in the chat. Feel free to ask questions while Hooman is going through the presentation and I'll jump in and stop them when needed.
|
||||
|
||||
|
||||
Demetrios:
|
||||
But also we can have a little discussion after a few minutes of slides. So for everyone looking, we're going to be watching this and then we're going to be checking out like really talking about what 2024 AI in the enterprise looks like and what is needed to really take advantage of that. So human, I'm dropping off to you, man, and I'll jump in when needed.
|
||||
But also we can have a little discussion after a few minutes of slides. So for everyone looking, we're going to be watching this and then we're going to be checking out like really talking about what 2024 AI in the enterprise looks like and what is needed to really take advantage of that. So Hooman, I'm dropping off to you, man, and I'll jump in when needed.
|
||||
|
||||
|
||||
Hooman Sedghamiz:
|
||||
Thanks a lot for the introduction. Let me get started. Do you have my screen already?
|
||||
@@ -96,10 +100,10 @@ Hooman Sedghamiz:
|
||||
So now you can imagine via is really important to us because it has the potential of unlocking a future where good health is a reality and hunger is a memory. So I maybe start about maybe giving you a hint of what are really the numerous use cases that AI or challenges that AI could help out with. In life science industry. You can think of adverse event detection when patients are taking a medication, too much of it. The patients might report adverse events, stomach bleeding and go to social media post about it. A few years back, it was really difficult to process automatically all this sort of natural text in a kind of scalable manner. But nowadays, thanks to large language models, it's possible to automate this and identify if there is a medication or anything that might have negatively an adverse event on a patient population. Similarly, you can now create a lot of marketing content using these large language models for products.
|
||||
|
||||
Hooman Sedghamiz:
|
||||
At the same time, drug discovery is making really big strides when it comes to identifying new compounds. You can essentially describe these compounds using formats like smiles, which could be represented as really text. And these large language models can be trained on them and they can predict the sequences. At the same time, you have this clinical trial outcome prediction, which is huge for pharmaceutical companies. If you could predict what will be the outcome of a trial, it would be a huge time and resource saving for a lot of companies. And of course, a lot of us already see in the market a lot of medical virtual assistants using large language models that can answer medical inquiries and give consultations around them. And there is really, I believe the biggest potential here is around real world data, like most of us nowadays, have some sort of sensor or watch that's measuring our health maybe at a minute by minute level, or it's measuring our heart rate. You go to the hospital, you have all your medical records recorded there, and these large language models have their capacity to process this complex data, and you will be able to drive better insights for individualized insights for patients.
|
||||
At the same time, drug discovery is making really big strides when it comes to identifying new compounds. You can essentially describe these compounds using formats like smiles, which could be represented as real text. And these large language models can be trained on them and they can predict the sequences. At the same time, you have this clinical trial outcome prediction, which is huge for pharmaceutical companies. If you could predict what will be the outcome of a trial, it would be a huge time and resource saving for a lot of companies. And of course, a lot of us already see in the market a lot of medical virtual assistants using large language models that can answer medical inquiries and give consultations around them. And there is really, I believe the biggest potential here is around real world data, like most of us nowadays, have some sort of sensor or watch that's measuring our health maybe at a minute by minute level, or it's measuring our heart rate. You go to the hospital, you have all your medical records recorded there, and these large language models have their capacity to process this complex data, and you will be able to drive better insights for individualized insights for patients.
|
||||
|
||||
Hooman Sedghamiz:
|
||||
And our company is also in crop science, as I mentioned, and crop yield prediction. If you could help farmers improve their crop yield, it means that they can produce better products faster with higher quality. So maybe I could start with maybe a history in 2023, what happened? How companies like ours were looking at large language models and opportunities. They bring, I think in 2023, everyone was excited to bring these efficiency games, right? Everyone wanted to use them for creating content, drafting emails, all these really low hanging fruit use cases. That was around. And one of the earlier really nice architectures that came up that I really like was from a 16 z enterprise that was, I think, back in really, really early 2023. LangChain was new, we had land chain and we had all this. Of course, Kudran been there for a long time, but it was the first time that you could see vector store products could be integrated into applications.
|
||||
And our company is also in crop science, as I mentioned, and crop yield prediction. If you could help farmers improve their crop yield, it means that they can produce better products faster with higher quality. So maybe I could start with maybe a history in 2023, what happened? How companies like ours were looking at large language models and opportunities. They bring, I think in 2023, everyone was excited to bring these efficiency games, right? Everyone wanted to use them for creating content, drafting emails, all these really low hanging fruit use cases. That was around. And one of the earlier really nice architectures that came up that I really like was from a 16 z enterprise that was, I think, back in really, really early 2023. LangChain was new, we had land chain and we had all this. Of course, Qdrant been there for a long time, but it was the first time that you could see vector store products could be integrated into applications.
|
||||
|
||||
Hooman Sedghamiz:
|
||||
Really at large scale. There are different components. It's quite complex architecture. So on the right side you see how you can host large language models. On the top you see how you can augment them using external data. Of course, we had these plugins, right? So you can connect these large language models with Google search APIs, all those sort of things, and some validation that are in the middle that you could use to validate the responses fast forward. Maybe I can kind of spend, let me check out the time. Maybe I can spend a few minutes about the components of LLM APIs and hosting because that I think has a lot of potential in terms of applications that need to be really scalable.
|
||||
@@ -111,10 +115,10 @@ Hooman Sedghamiz:
|
||||
And we know that most of the users won't use that. We know that it's a usage based application. You just probably go there. Depending on your daily work, you probably use it. Some people don't use it heavily. I kind of did some calculation. If you build it in house using APIs that you can access yourself, and large language models that corporations can deploy internally and locally, that cost saving could be huge, really magnitudes cheaper, maybe 30 to 20 to 30 times cheaper. So looking, comparing 2024 to 2023, a lot of things have changed.
|
||||
|
||||
Hooman Sedghamiz:
|
||||
Like if you look at the open source large language models that came out really great models from Mistral, now we have models like Llama, two based model, all of these models came out. You can now kind of take a look and see that the performance of them is really, really getting close, if not better than GPT 3.5 already at same level and really approaching step by step to GPT four. And looking at the price on the right side and speed or throughput, you can see that like for example, Mixtrawl seven eight B could be a really cheap option to deploy. And also the performance of it gets really close to GPT 3.5 for many use cases in the enterprise companies. I think two of the big things this year, end of last year that came out that make this kind of really a reality are really a few large language models. I don't know if I can call them large language models. They are like 7 billion to 13 billion compared to GPT four, GT 3.5. I don't think they are really large.
|
||||
Like if you look at the open source large language models that came out really great models from Mistral, now we have models like Llama, two based model, all of these models came out. You can now kind of take a look and see that the performance of them is really, really getting close, if not better than GPT 3.5 already at same level and really approaching step by step to GPT 4. And looking at the price on the right side and speed or throughput, you can see that like for example, Mistral seven eight B could be a really cheap option to deploy. And also the performance of it gets really close to GPT 3.5 for many use cases in the enterprise companies. I think two of the big things this year, end of last year that came out that make this kind of really a reality are really a few large language models. I don't know if I can call them large language models. They are like 7 billion to 13 billion compared to GPT four, GT 3.5. I don't think they are really large.
|
||||
|
||||
Hooman Sedghamiz:
|
||||
But one was Nexus, Raven. We know that applications, if they want to be robust, they really need function calling. We are seeing this paradigm of function calling, which essentially you ask a language model to generate structured output, you give it a function signature, right? You ask it to generate an output, structured output argument for that function. Next was Raven came out last year, that, as you can see here, really is getting really close to GPT four, right? And GPT four being magnitude bigger than this model. This model only being 13 billion parameters really provides really less hallucination, but at the same time really high quality of function calling. So this makes me really excited for the open source and also the companies that want to build their own applications that requires function calling. That was really lacking maybe just five months ago. At the same time, we have really dedicated large language models to programming languages or scripting like SQL, that we are also seeing like SQL coder that's already beating GPT four.
|
||||
But one was Nexus Raven. We know that applications, if they want to be robust, they really need function calling. We are seeing this paradigm of function calling, which essentially you ask a language model to generate structured output, you give it a function signature, right? You ask it to generate an output, structured output argument for that function. Next was Raven came out last year, that, as you can see here, really is getting really close to GPT four, right? And GPT four being magnitude bigger than this model. This model only being 13 billion parameters really provides really less hallucination, but at the same time really high quality of function calling. So this makes me really excited for the open source and also the companies that want to build their own applications that requires function calling. That was really lacking maybe just five months ago. At the same time, we have really dedicated large language models to programming languages or scripting like SQL, that we are also seeing like SQL coder that's already beating GPT four.
|
||||
|
||||
Hooman Sedghamiz:
|
||||
So maybe we can now quickly take a look at how model solving will look like for a large company like ours, like companies that have a lot of people across the globe again, in this aspect also, the community has made really big progress, right? So we have text generation inference from hugging face is open source for most purposes, can be used and it's the choice of mine and probably my group prefers this option. But we have Olama, which is great, a lot of people are using it. We have llama CPP which really optimizes the large language models for local deployment as well, and edge devices. I was really amazed seeing Raspberry PI running a large language model, right? Using Llama CPP. And you have this text generation inference that offers quantization support, continuous patching, all those sort of things that make these large LLMs more quantized or more compressed and also more suitable for deployment to large group of people. Maybe I can kind of give you kind of a quick summary of how, if you decide to deploy these large language models, what techniques you could use to make them more efficient, cost friendly and more scalable. So we have a lot of great open source projects like we have Lite LLM which essentially creates an open AI kind of signature on top of your large language models that you have deployed. Let's say you want to use Azure to host or to access GPT four gypty 3.5 or OpenAI to access OpenAI API.
|
||||
|
||||
Reference in New Issue
Block a user